Video

Could New Treatment Be a Cure for Ventricular Assist Device Patients?

Author(s):

By the time patients need a left ventricular assist device their condition has already worsened considerably. With the help of a combination of technology and medication there is some research to show that improvement is possible in many patients.

By the time patients need a left ventricular assist device their condition has already worsened considerably. With the help of a combination of technology and medication there is some research to show that improvement is possible in many patients.

While attending the annual American Heart Association's Scientific Sessions in New Orleans, John Gorcsan III, MD, from UPMC, said results of a study based out of the University of Louisville could be a game changer for patients and providers alike if long term research on the topic shows the same results. While only one part of the team at the Pittsburgh institution, Gorcsan said the results could change the way patients are treated with the device in order to have the best results possible.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.